Ulcerative Colitis (UC)
Pipeline by Development Stage
Drug Modality Breakdown
On Market (8)
Approved therapies currently available
Competitive Landscape
6 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
Clinical Trials (12)
Total enrollment: 4,324 patients across 12 trials
A Study to Assess Adverse Events and Change in Disease Condition of Mesalamine Capsules in Children Aged 5 to 17 Years With Ulcerative Colitis
A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Ulcerative Colitis
A Study to Evaluate the Long-Term Safety and Efficacy of Upadacitinib (ABT-494) in Participants With Ulcerative Colitis (UC)
Study to Evaluate the Safety and Efficacy of Two Adalimumab Dosing Regimens in Subjects With Moderate to Severe Ulcerative Colitis
A Study to Investigate How Well Ravagalimab (ABBV-323) Works and How Safe it is in Participants With Moderate to Severe Ulcerative Colitis Who Failed Prior Therapy
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
Evaluate the Safety, Tolerability, PK and PD of SAD of Intravenously Adminsterted ALTB-268 in Healthy Participants
A Study to Evaluate the Effect of Intravenous (IV) Infusions of Risankizumab on Pharmacokinetics of Cytochome P450 Substrates in Adult Participants With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease
An Observational Study to Learn About Velsipity After Long Term Use in Patients With Ulcerative Colitis
Zymfentra (Infliximab-dyyb) REal World Cohort STudy
AI-driven Narrow-band Imaging Score for Disease Assessment and Outcome Prediction in Ulcerative Colitis
Assessing Effectiveness of Adalimumab for Treating Ulcerative Colitis in Real Life Conditions